Wuhan Tianan Hospital, formerly known as Hubei Expert Diagnosis and Treatment Center of Integrated Traditional Chinese and Western Medicine, was expanded in 2003 to a comprehensive integrated hospital with specialties of gastroenterology, thyroid, andrology, Bigfoot and hematology. The hospital is located at No.57, with a business area of more than 5,000 square meters and total assets of nearly 50 million yuan. The construction of hardware facilities and medical technology level refers to the national second-class first-class hospitals. The characteristics of the hospital are outstanding, such as the treatment of hematological diseases and thyroid diseases with integrated traditional Chinese and western medicine, which has reached the advanced level of the same industry in the region.
hematology
Wuhan Tianan Hospital is at the main entrance.
Atlas of the main entrance of Wuhan Tianan Hospital
Hematology is the key characteristic department of Tianan Hospital. With Yang Jinfei, the former chief physician and Jin Yang, the former center for diagnosis and treatment of hematological diseases in Hubei Province, as academic leaders, our department has a large number of young and middle-aged professionals with outstanding achievements in the field of hematological diseases. After more than forty years of clinical practice and exploration, a relatively complete diagnosis and treatment system of blood diseases with integrated traditional Chinese and western medicine has been formed, especially in the treatment of aplastic anemia, thrombocytopenia and leukemia. Chief physician Yang Jinfei successfully developed specialized drugs such as Regenerated Syrup, Anxue Tablet and Bai Sheng Tablet, which were officially approved as hospital preparations by Hubei Drug Administration, and achieved remarkable clinical effects. Among them, recycled syrup also won the provincial scientific research achievement award. Since the establishment of hematology department in our hospital for more than 40 years, * * * has treated more than 654.38+million patients with various hematological diseases both inside and outside the province, with an effective rate of over 96%. It has been well received by patients and the industry and has become an influential research center for blood disease treatment in Central and South China.
If you think it's good, please adopt it. Thank you.